Tenax Therapeutics (TENX) Enterprise Value: 2010-2017
Historic Enterprise Value for Tenax Therapeutics (TENX) over the last 7 years, with Dec 2017 value amounting to $7.5 million.
- Tenax Therapeutics' Enterprise Value fell 82.02% to $7.5 million in Q4 2017 from the same period last year, while for Dec 2017 it was $7.5 million, marking a year-over-year decrease of 64.21%. This contributed to the annual value of $24.9 million for FY2024, which is 279.31% up from last year.
- Latest data reveals that Tenax Therapeutics reported Enterprise Value of $7.5 million as of Q4 2017, which was up 351.72% from $1.7 million recorded in Q3 2017.
- In the past 5 years, Tenax Therapeutics' Enterprise Value ranged from a high of $111.3 million in Q4 2014 and a low of $1.7 million during Q3 2017.
- In the last 3 years, Tenax Therapeutics' Enterprise Value had a median value of $48.0 million in 2016 and averaged $47.1 million.
- As far as peak fluctuations go, Tenax Therapeutics' Enterprise Value surged by 1,423.02% in 2014, and later tumbled by 97.13% in 2017.
- Tenax Therapeutics' Enterprise Value (Quarterly) stood at $15.4 million in 2013, then soared by 623.87% to $111.3 million in 2014, then dropped by 1.24% to $38.3 million in 2015, then climbed by 8.49% to $41.6 million in 2016, then slumped by 82.02% to $7.5 million in 2017.
- Its Enterprise Value stands at $7.5 million for Q4 2017, versus $1.7 million for Q3 2017 and $12.1 million for Q2 2017.